HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer
2019 · The Oncologist · 165 citations
https://doi.org/10.1634/theoncologist.2018-0785
C
C. Vaghi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
272
Citations
4
h-index
4
i10-index
C. Vaghi is an academic researcher from Vall d'Hebron Hospital Universitari. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer. The author has an h-index of 4, co-authored 19 publications.
ORCID: 0000-0001-5023-3521Papers by this author
worksLiquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
2021 · Targeted Oncology · 32 citations
https://doi.org/10.1007/s11523-021-00795-5
The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review
2022 · Cancer Treatment Reviews · 22 citations
https://doi.org/10.1016/j.ctrv.2022.102488
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies
2025 · Drugs · 4 citations
https://doi.org/10.1007/s40265-025-02253-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat